NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, ...
Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...
NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, ...
The collection — the largest of its kind — contains more than 18,700 adverts that were posted between March 2020 and early ...
Mayor Zohran Mamdani signaled Monday he is more open to the NYPD’s controversial gang database, crediting the department for implementing reforms rather than reiterating his campaign promise to ...
An Oakland patrol officer has been charged with two misdemeanors for allegedly using a controlled law enforcement database ...
Objectives Over the last decade, a growing number of health interventions (eg, medical assistance in dying and mitochondrial ...
Support journalism that covers the topics that matter most to you. Donate today to preserve the quality and integrity of local journalism.
The system prompt for OpenAI’s Codex CLI contains a perplexing and repeated warning for the most recent GPT model to “never ...
It uses Opus 4.7 to scan, validate, and generate patches, helping fix dangerous flaws before they can be exploited.
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE)-- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, ...
If Apple's AI tech isn't for you, here's how you can disable all or parts of it. Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide ...